Evaluating the non-inferiority of HIPEC with mitomycin C 10 mg/m 2 for 60 min versus HIPEC with mitomycin C 35 mg/m 2 for 90 min in the treatment of pseudomyxoma peritonei from perforated epithelial mucinous tumours of the appendix (HIPEC-PMP): protocol for a single-blinded, randomised controlled trial

Sean Ewings, Sophia Stanford, Chris Wignall, Karen Martin, Pavel Mozgunov, Gianmarco Caruso, Louise Holmes, Paul Smith, David Scott, Gareth Griffiths, Alexios Tzivanakis, Sanjeev Dayal, Vasanth Mark Samuel, Gui Han Lee, Brendan Moran, Faheez Mohamed, Tom Cecil

Open source

DOI: 10.1136/bmjgast-2025-002187
Published: 2026-11
Container: BMJ Open Gastroenterology
Publisher: BMJ
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bmjgast-2025-002187,
  title = {Evaluating the non-inferiority of HIPEC with mitomycin C 10 mg/m
                    <sup>2</sup>
                    for 60 min versus HIPEC with mitomycin C 35 mg/m
                    <sup>2</sup>
                    for 90 min in the treatment of pseudomyxoma peritonei from perforated epithelial mucinous tumours of the appendix (HIPEC-PMP): protocol for a single-blinded, randomised controlled trial},
  author = {Sean Ewings and Sophia Stanford and Chris Wignall and Karen Martin and Pavel Mozgunov and Gianmarco Caruso and Louise Holmes and Paul Smith and David Scott and Gareth Griffiths and Alexios Tzivanakis and Sanjeev Dayal and Vasanth Mark Samuel and Gui Han Lee and Brendan Moran and Faheez Mohamed and Tom Cecil},
  year = {2026},
  journal = {BMJ Open Gastroenterology},
  doi = {10.1136/bmjgast-2025-002187},
  url = {https://doi.org/10.1136/bmjgast-2025-002187}
}

RIS

TY  - JOUR
TI  - Evaluating the non-inferiority of HIPEC with mitomycin C 10 mg/m
                    <sup>2</sup>
                    for 60 min versus HIPEC with mitomycin C 35 mg/m
                    <sup>2</sup>
                    for 90 min in the treatment of pseudomyxoma peritonei from perforated epithelial mucinous tumours of the appendix (HIPEC-PMP): protocol for a single-blinded, randomised controlled trial
AU  - Sean Ewings
AU  - Sophia Stanford
AU  - Chris Wignall
AU  - Karen Martin
AU  - Pavel Mozgunov
AU  - Gianmarco Caruso
AU  - Louise Holmes
AU  - Paul Smith
AU  - David Scott
AU  - Gareth Griffiths
AU  - Alexios Tzivanakis
AU  - Sanjeev Dayal
AU  - Vasanth Mark Samuel
AU  - Gui Han Lee
AU  - Brendan Moran
AU  - Faheez Mohamed
AU  - Tom Cecil
PY  - 2026
JO  - BMJ Open Gastroenterology
DO  - 10.1136/bmjgast-2025-002187
UR  - https://doi.org/10.1136/bmjgast-2025-002187
ER  -

APA

Ewings, S., Stanford, S., Wignall, C., Martin, K., Mozgunov, P., Caruso, G., Holmes, L., Smith, P., Scott, D., Griffiths, G., Tzivanakis, A., Dayal, S., Samuel, V. M., Lee, G. H., Moran, B., Mohamed, F., & Cecil, T. (2026). Evaluating the non-inferiority of HIPEC with mitomycin C 10 mg/m 2 for 60 min versus HIPEC with mitomycin C 35 mg/m 2 for 90 min in the treatment of pseudomyxoma peritonei from perforated epithelial mucinous tumours of the appendix (HIPEC-PMP): protocol for a single-blinded, randomised controlled trial. BMJ Open Gastroenterology. https://doi.org/10.1136/bmjgast-2025-002187

Source records

crossref · retrieved 2026-11-07T15:11:28.554Z